PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Beschikbaar vanaf:

Arrotex Pharmaceuticals Pty Ltd

INN (Algemene Internationale Benaming):

pramipexole dihydrochloride monohydrate

farmaceutische vorm:

Tablet, uncoated

Samenstelling:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

Toedieningsweg:

Oral

Eenheden in pakket:

10, 30, 100

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Product samenvatting:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisatie-status:

Licence status A

Autorisatie datum:

2014-09-23